Gelesis to Report Third Quarter 2022 Financial Results on November 14, 2022

Rhea-AI Summary

Gelesis Holdings (NYSE: GLS) announced it will report its third-quarter financial results for the period ending September 30, 2022, on November 14, 2022, before the market opens. A live conference call will be held at 8:30 a.m. ET on the same day to discuss the results. Gelesis is known for its weight management product, Plenity®, which is designed to aid in weight management and is inspired by natural ingredients.

BOSTON--(BUSINESS WIRE)-- Gelesis Holdings, Inc. (NYSE:GLS) (“Gelesis” or the “Company”), the maker of Plenity® for weight management, today announced that the Company will report financial results for the third quarter ended September 30, 2022, on November 14, 2022 prior to the market open. Gelesis management will host a live conference call and webcast at 8:30 a.m. ET on the same day to discuss the results.

Gelesis is a consumer-centered biotherapeutics company and the maker of Plenity for weight management. (Photo: Business Wire)

The live call can be accessed via webcast on the “Events & Presentations” section of the Gelesis Investor Relations website at https://ir.gelesis.com/. The webcast will also be archived and available for replay shortly after the call has concluded. Those who are interested in participating in the live call can dial 844-200-6205 from the U.S. and 929-526-1599 internationally, and enter the access code 849038.

About Gelesis

Gelesis Holdings Inc. (NYSE: GLS) (“Gelesis”) is a consumer-centered biotherapeutics company and the maker of Plenity®, which is inspired by nature and FDA cleared to aid in weight management. Our first-of-their-kind non-systemic superabsorbent hydrogels are made entirely from naturally derived building blocks. They are inspired by the composition and mechanical properties of raw vegetables, taken by capsule, and act locally in the digestive system, so people feel satisfied with smaller portions. Our portfolio includes Plenity® and potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation. For more information, visit gelesis.com, or connect with us on Twitter @GelesisInc. Plenity® is indicated to aid weight management in adults with excess weight or obesity, a Body Mass Index (BMI) of 25–40 kg/m², when used in conjunction with diet and exercise.

Important Safety Information about Plenity

• Patients who are pregnant or are allergic to cellulose, citric acid, sodium stearyl fumarate, gelatin, or titanium dioxide should not take Plenity.
• To avoid impact on the absorption of medications:
  • For all medications that should be taken with food, take them after starting a meal.
  • For all medications that should be taken without food (on an empty stomach), continue taking on an empty stomach or as recommended by your physician.
• The overall incidence of side effects with Plenity was no different than placebo. The most common side effects were diarrhea, distended abdomen, infrequent bowel movements, and flatulence.
• Contact a doctor right away if problems occur. If you have a severe allergic reaction, severe stomach pain, or severe diarrhea, stop using Plenity until you can speak to your doctor.

Rx Only. For the safe and proper use of Plenity or more information, talk to a healthcare professional, read the Patient Instructions for Use, or call 1-844-PLENITY.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221107005166/en/

Investors & Media:

Katie Sullivan

ksullivan@gelesis.com

Source: Gelesis Holdings, Inc.

FAQ

When will Gelesis report its third-quarter financial results for 2022?

Gelesis will report its third-quarter financial results for the year on November 14, 2022.

What product is Gelesis known for?

Gelesis is known for its weight management product, Plenity®.

What time is the Gelesis conference call on November 14, 2022?

The live conference call will be held at 8:30 a.m. ET on November 14, 2022.

How can I access the Gelesis financial results webcast?

The webcast can be accessed via the 'Events & Presentations' section of the Gelesis Investor Relations website.

What is the stock symbol for Gelesis?

The stock symbol for Gelesis is GLS.